In vitro evaluation of proniosomes as a drug carrier for flurbiprofen

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 782-790

  Ibrahim, Mahmoud Mokhtar Ahmed ^a   Sammour, Omaima A ^b   Hammad, Mohamed A ^a   Megrab, Nagia A ^a  

^a Zagazig University   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Cholesterol; Flurbiprofen; Gel; Liquid crystal; Non ionic surfactant; Proniosomes

Indexed keywords

ALCOHOL; CELLOPHANE; CHOLESTEROL; DRUG CARRIER; FLURBIPROFEN; HYDROXYPROPYLMETHYLCELLULOSE; NONIONIC SURFACTANT; SORBITAN LAURATE; SORBITAN OLEATE; SORBITAN PALMITATE; SORBITAN STEARATE; WATER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISPERSION; DISTILLATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; DRUG TRANSPORT; HYDRATION; IN VITRO STUDY; MALE; NONHUMAN; RABBIT; SKIN; SKIN PERMEABILITY; SUSPENSION;

ANIMALS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FLURBIPROFEN; LIPOSOMES; MALE; PRODRUGS; RABBITS; SKIN ABSORPTION;

EID: 57149129875     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9114-0     Document Type: Article

References (33)

1. D. N. Reddy, and N. Udupa. Formulation and evaluation of oral and transdermal preparations of flurbiprofen and piroxicam incorporated with different carriers. Drug Dev. Ind. Pharm. 19: 843-852 (1993).
2. H. Schreier, and J. Bouwstra. Liposomes and niosomes as topical drug carriers dermal and transdermal drug delivery. J. Control. Rel. 30: 1-15 (1994).
3. D. Vanhal, A. Vanrensen, T. Devringer, H. Junginger, and J. Bouwstra. Diffusion of estradiol from non ionic surfactant vesicles through human stratum corneum in vitro. STP Pharm. Sci. 6: 72-78 (1996).
4. I. F. Uchegbu, and S. P. Vyas. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 172: 33-70 (1998).
5. J. Varshosaz, A. Pardakhty, and M. H. B. Seied. Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate. Drug Deliv. 12: 75-82 (2005).
6. H. E. J. Hofland, J. A. Bouwstra, M. Ponec, H. E. Bodde, F. Spies, J. Coos Verhoef, and H. E. Junginger. Interactions of non ionic surfactant vesicles with cultured keratinocytes and human skin in vitro: A survey of toxicological aspects and ultrastructural changes in stratum corneum. J. Control. Rel. 16: 155-168 (1991).
7. D. Aggarwal, D. Pal, A. K. Mitra, and I. P. Kaur. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int. J. Pharm. 338: 21-26 (2007).
8. B. Vora, A. J. Khopade, and N. K. Jain. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control. Rel. 54: 149-165 (1998).
9. B. D. Anderson, and R. A. Conradi. Predictive relationships in the water solubility of salts of a non steroidal anti-inflammatory drug. J. Pharm. Sci. 74: 815-820 (1985).
10. H. Kitagawa, T. Sakai, H. Saito, M. Mori, R. Tazoe, T. Sugibayashi, and A. Nomura. Anti-inflammatory and analgesic actions and skin irritation of flurbiprofen by dermal application. Lyakuhin Kenkyu. 13: 869-878 (1993).
11. K. Kyuki, K. Tsurumi, H. Fujimura, S. Masumoto, and Y. Hashimoto. Anti-inflammatory effect of flurbiprofen for dermal application (FP-A). Iyakuhin Kenkyu. 15: 293-298 (1984).
12. S. Masumoto, T. Akiba, M. Okumura, K. Ichikawa, and Y. Hashimoto. Anti-inflammatory effect of flurbiprofen by topical application. Iyakuhin Kenkyu. 13: 878-885 (1982).
13. A. H. Kibbe (ed), Handbook of Pharmaceutical Excepients, 3rd edn. American Pharmaceutical Association, Washington, D.C, 2000, pp. 511-514.
14. P. Sebastiani, S. Nicoli, and P. Santi. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin. Int. J. Pharm. 292: 119-126 (2005).
15. E. Larrucea, A. Arellano, S. Santoyo, and P. Ygartua. Interaction of tenoxicam with cyclodextrins and its influence on the in vitro percutaneous penetration of the drug. Drug Dev. Ind. Pharm. 27 (3):251-260 (2001).
16. P. Mura, M.T. Faucci, G. Bramanti, and P. Corti. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur. J. Pharm. Sci. 9: 365-372 (2000).
17. D. Attwood and A. T. Florence. Surfactant systems, their chemistry, pharmacy and biology, Chapman and Hall, London, 1983.
18. M. Sudaxshiina, B. Benedicte Van Den, G. Gregory, and T. F. Alexander. Water in sorbitan monostearate organogels (water in oil gels). J. Pharm. Sci. 88 (6):615-619 (1999a).
19. M. Sudaxshiina, G. Gregory, and T. F. Alexander. Interaction of nonionic surfactant based organogel with aqueous media. Int. J. Pharm. 180: 211-214 (1999b).
20. A. Martin, J. Swarbrick, and A. Cammarata. Physical Pharmacy, 3rd ed., Lea and Febiger, Philadelphia, 1993, pp. 496-501.
21. B. Godin, and E. Touitou. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Deliver. Rev. 59: 1152-1161 (2007).
22. T. Yoshioka, B. Sternberg, and A. T. Florence. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and sorbitan triester (Span 85). Int. J. Pharm. 105: 1-6 (1994).
23. J. Y. Fang, S. Y. Yu, P. C. Wu, Y. B. Huang, and Y. H. Tsai. In vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. 215: 91-99 (2001).
24. C. Valenta, M. Wanka, and J. Heidlas. Evaluation of novel soyalecithin formulations for dermal use containing ketoprofen as a model drug. J. Control. Rel. 63: 165-173 (2000).
25. P. N. Gupta, V. Mishra, A. Rawat, P. Dubey, S. Mahor, S. Jain, D. P. Chatterji, and S. P. Vyas. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: A comparative study. Int. J. Pharm. 293 (1-2):73-82 (2005).
26. B. D. Ladbrooke, R. M. Williams, and D. Chapman. Studies on lecithin-cholesterol-water interactions by differential scanning calorimetry and x-ray diffraction. Biochim. Biophys. Acta. 150: 333-340 (1968).
27. D. Papahadjopoulos, K. Jacobson, S. Nir, and T. Isac. Phase transition in phospholipid vesicles: Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta. 311: 330-334 (1973).
28. I. A. Alsarra, A. A. Bosela, S. M. Ahmed, and G. M. Mahrous. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. and Biopharm. Xx: 1-6 (2004).
29. H. G. Ibrahim. Release studies from lyotropic liquid crystal systems. J. Pharm. Sci. 78 (8):683-687 (1989).
30. M. Ramírez-Campos, and L. Villafuerte-Robles. Effect of formulation variables on verapamil hydrochloride release from hydrated HPMC matrices. Rev. Soc. Quím. Méx. 48: 326-331 (2004).
31. D. K. Parikh, and T. K. Ghosh. Feasibility of transdermal delivery of fluoxetine. AAPS PharmSciTech. 6 (2):144-149 (2005).
32. N. A. Megrab, A. C. Williams, and B. W. Barry. Oestradiol permeation across human skin, silastic and snake skin membranes: The effects of ethanol/water co-solvent systems. Int. J. Pharm. 116: 101-112 (1995).
33. B. Y. Hwang, B. H. Jung, S. J. Chung, M. H. Lee, and C. K. Shim. In vitro skin permeation of nicotine from proliposomes. J. Control. Rel. 49: 177-184 (1997).